Pierre E. G. Etienne
Nessuna posizione attualmente
Profilo
Dr. Pierre E.
Etienne, MD, is a Principal at Decision Options LLC.
In addition to his role with Decision Options, Dr. Etienne is Chief Development Officer of Targanta Therapeutics, Inc. and Targanta Therapeutics Corp.
He was a Senior Executive in Pfizer Worldwide Development Operations.
He is a Director of ESVEE Pharmaceuticals Private Limited in Pune, India, on the Advisory Board of Del-Mar Therapeutics, La Jolla, CA, and on the development council of Neurogen, Inc. in Branford, CT.
Dr. Etienne holds an MD from Univeristé de Liège, Belgium and trained in Neurochemistry and Psychiatry at McGill University in Montreal.
Precedenti posizioni note di Pierre E. G. Etienne
| Società | Posizione | Fine |
|---|---|---|
Targanta Therapeutics Corp.
 Targanta Therapeutics Corp. BiotechnologyHealth Technology Targanta Therapeutics Corp. discovers and develops novel antibacterial pro drugs. The company was founded in 1997 and is headquartered in Parsippany, NJ. | Corporate Officer/Principal | 30/06/2010 |
Ciba-Geigy AG
 Ciba-Geigy AG Pharmaceuticals: MajorHealth Technology Ciba-Geigy AG was manufacturing pharmaceuticals. The company was merged with Sandoz Ltd. to create Novartis AG. The company was founded in 1884 and was headquartered in Basle, Switzerland. | Corporate Officer/Principal | - |
Decision Options LLC
 Decision Options LLC Investment ManagersFinance Decision Options LLC is a privately held, SEC-registered investment advisor and hedge fund manager headquartered in Groton, Connecticut. The firm was founded by Gill Eapen in 2001 to initially provide consultation and software for real estate valuation and portfolio management. They expanded the firm’s services to include investment advisory services for individual and institutional clients, thereafter. | Analyst-Equity | - |
| PFIZER, INC. | Direttore operativo | - |
Formazione di Pierre E. G. Etienne
| University of Liege | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PFIZER, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Targanta Therapeutics Corp.
Targanta Therapeutics Corp. BiotechnologyHealth Technology Targanta Therapeutics Corp. discovers and develops novel antibacterial pro drugs. The company was founded in 1997 and is headquartered in Parsippany, NJ. | Health Technology |
Decision Options LLC
Decision Options LLC Investment ManagersFinance Decision Options LLC is a privately held, SEC-registered investment advisor and hedge fund manager headquartered in Groton, Connecticut. The firm was founded by Gill Eapen in 2001 to initially provide consultation and software for real estate valuation and portfolio management. They expanded the firm’s services to include investment advisory services for individual and institutional clients, thereafter. | Finance |
Ciba-Geigy AG
Ciba-Geigy AG Pharmaceuticals: MajorHealth Technology Ciba-Geigy AG was manufacturing pharmaceuticals. The company was merged with Sandoz Ltd. to create Novartis AG. The company was founded in 1884 and was headquartered in Basle, Switzerland. | Health Technology |
- Borsa valori
- Insiders
- Pierre E. G. Etienne
